Semaglutide and Bone Fracture Risk: What People With Type 2 Diabetes Should Know 24th September 202624th June 2026 by Living Diabetes Editorial An ENDO 2026 real-world study linked semaglutide with fewer bone fractures than several other weight-loss medicines in adults with type 2 diabetes. The finding is interesting, but it does not prove semaglutide prevents fractures.
Ozempic, Wegovy, and Mounjaro: Key Differences 6th June 202610th March 2026 by Living Diabetes Editorial Ozempic, Wegovy, and Mounjaro are related but not interchangeable. Learn label differences, safety issues, and questions to ask.
